Canada: Mise en œuvre du pouvoir qu'a Santé Canada d'évaluer les instruments médicaux après leur approbation : Le point sur le processus de consultation réglementaire

En 2014, des modifications apportées à la Loi sur les aliments et drogues ont conféré au ministre fédéral de la Santé le pouvoir de régir la sûreté des médicaments, des instruments médicaux et des autres appareils thérapeutiques qui sont déjà sur le marché. Parmi les pouvoirs précis qui lui ont été délégués par les modifications, on compte la capacité d'exiger des études, des tests et des analyses de coûts-avantages supplémentaires. Les modifications à la réglementation visant précisément les médicaments ont été mises en Suvre en 2018. Tel qu'il est expliqué dans la présente mise à jour, Santé Canada mène actuellement un processus de consultation relativement aux changements réglementaires qui seront nécessaires pour pleinement mettre en Suvre les modifications de 2014 qui concernent les instruments médicaux.

Une traduction de ce billet sera disponible prochainement.

In 2014, amendments to the Food and Drugs Act gave the federal Minister of Health authority with respect to the safety of drugs, medical devices and other therapeutic devices that are already on the market. The specific powers conferred by the amendment included the ability to compel further studies, testing and cost-benefit assessments. Changes to the regulations relating specifically to drugs were implemented in 2018 and, as discussed in this update, Health Canada is now partway through a consultation process with respect to regulatory changes that will be needed to fully implement the 2014 amendments with respect to medical devices.

On June 14, 2019, Health Canada launched a new phase of the medical device consultation process in which the general public is invited to comment on the proposed regulations. This latest step in the process, considered in detail below, follows an industry-focused costing survey that was sent in January of this year to members of each of the following key stakeholder groups: medical device licence holders ("MDLHs"), establishment licence holders for importation, Class I medical device manufacturers and industry associations.

The deadline for comments on the current public consultation phase is August 26, 2019. The text of the proposed amendments is available in the June 15, 2019 Canada Gazette, following the Regulatory Impact Analysis Statement.


Health Canada's proposed amendments are focused primarily on three substantive objectives:

1.    Clarifying certain details of how the Food and Drugs Act provisions are to be operationalized

One purpose of Health Canada's proposed regulatory changes is to fill in some of the details about process that are necessary to make the 2014 Food and Drugs Act amendments workable, notably with respect to the Minister of Health's authority to order MDLHs of Class II, III and IV medical devices to conduct assessments, additional tests and studies, to monitor experiences, and/or to collect information about devices after they have gone on the market.

In addition, the amended regulations will harmonize the regulatory provisions concerning therapeutic drugs and therapeutic medical devices as they relate to tests and assessments.

2.    Improving the reporting of foreign incidents and regulatory actions

Currently, incidents that occur outside Canada are required to reported to Health Canada only if the regulatory agency of the country in which the incident occurred has required the manufacturer to take corrective action or the manufacturer advised that regulatory agency that it intends to do so.

In Health Canada's view, this process is inadequate for a variety of reasons. For example, there is no set time-frame for such a report, nor is there any requirement to identify the corrective actions taken in response to the incident. The proposed amendments will accordingly require MDLHs and importers of Class II, III and IV medical devices to advise Health Canada within 72 hours, in the event that they or certain foreign regulators take any of the following actions with respect to a "serious risk" related to a medical device that is marketed in Canada:

  • Communicate the risks related to the medical device;
  • Change the labels on the medical device;
  • Begin a product recall process;
  • Begin a reassessment; and
  • Suspend or revoke a medical device licence.

The list of foreign jurisdictions would be limited to members of the International Medical Device Regulators Forum or other countries with which Health Canada has a mutual recognition agreement or similar memorandum of understanding in this area. According to Health Canada, fewer than 20 jurisdictions currently meet those standards.

3.    Making post-market surveillance more effective

Health Canada is proposing two additional regulatory changes that are intended to improve its ability to conduct post-market surveillance of medical devices.

Through annual summary reports

These regulatory changes will require MDLHs of Class II, III and IV medical devices to prepare an annual report detailing whether (i) there has been a decrease in any of the benefits of the device; (ii) the risks are more likely to occur; (iii) the consequences for patients or users may be more serious, if a risk occurs; or (iv) any new risks have been identified. Where the MDLH finds that there has been such a change in the risks or benefits of the medical device, the proposed regulations will require the MDLH to notify Health Canada in writing within 72 hours.

Through issue-related analysis of safety and effectiveness

The proposed regulation seeks to empower the Minister of Health with the ability to order manufacturers of Class I devices and MDLHs of Class II, III and IV medical devices to prepare an analysis on an issue related to the safety and effectiveness of a device. Such orders will be issued where the Minister requires an analysis in order to complete a post-market review of the safety and effectiveness of a medical device in response to a signal regarding the device. Although there is no current guidance on the form of this "analysis", Health Canada has advised that it will provide details in due course and expects that it will require an analysis of device incidents, exposure data, the manufacturer's conclusions regarding the safety and effectiveness of the device, and a risk mitigation strategy, if necessary.

The proposed regulation also contemplates that the Minister will have the authority to suspend the MDLH's licence or to order a stop sale of Class I devices in the event that the MDLH fails to prepare the analysis when ordered to do so.


Finally, the new regulations will ensure that medical devices will automatically be required to comply with the latest ISO standard as soon as it becomes official. Essentially what this means is that it will no longer be necessary to amend the name of the relevant ISO standard in the regulations. Health Canada is taking this approach in order to eliminate the existing lag-time after ISO standards change, ensuring that Canadian requirements are always in line with those of other major jurisdictions.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Smart & Biggar
In association with
Practice Guides
by Mondaq Advice Centres
Relevancy Powered by MondaqAI
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Smart & Biggar
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions